NuvoAir

NuvoAir

Digital respiratory care platform with devices

About NuvoAir

Simplify's Rating
Why NuvoAir is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

Healthcare

Company Size

51-200

Company Stage

Series A

Total Funding

$28.2M

Headquarters

Boston, Massachusetts

Founded

2017

Overview

NuvoAir provides a digital care platform for people with asthma and COPD. It combines at-home devices, real-time health data, and virtual visits with a dedicated care team to help patients manage their respiratory conditions. Patients or clinics subscribe to the service and pay for ongoing access to the technology and care services. The platform works by collecting data from devices and user input, sharing it with clinicians, and enabling remote consultations so doctors can make informed treatment decisions. NuvoAir differentiates itself by offering end-to-end support that includes hardware, software, and a care team, along with a free clinic trial and nationwide availability in all 50 U.S. states. This approach has yielded measurable results, such as fewer urgent consultations and strong user retention. The company aims to improve respiratory health outcomes by enabling proactive, data-driven care for patients, providers, and researchers.

Simplify Jobs

Simplify's Take

What believers are saying

  • Privia partnership extends reach to 515,000 patients across Georgia's highest-performing ACO network.[7]
  • Air Next 510(k) clearance unlocks reimbursement for home spirometry, a core clinical and revenue differentiator.[3]
  • Demonstrated 80% hospitalization reduction and 60% exacerbation decrease drive health plan contract expansion.[7]

What critics are saying

  • CMS may deny or reduce home spirometry reimbursement by 2026-2027, eliminating core revenue driver.[3]
  • Optum and UnitedHealth build competing virtual cardiopulmonary programs, undercutting NuvoAir pricing by 30-40%.[2]
  • Patient device non-compliance below 40% deteriorates outcomes, triggering health plan contract terminations.[1]

What makes NuvoAir unique

  • FDA-cleared Air Next spirometer enables continuous home-based lung monitoring unavailable from competitors.[3]
  • Multidisciplinary virtual team including pulmonologists, cardiologists, and therapists delivers integrated cardiopulmonary care at scale.[8]
  • Proprietary analytics engine predicts exacerbations in real-time, enabling intervention before hospitalization becomes necessary.[6]

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$28.2M

Meets

Industry Average

Funded Over

4 Rounds

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Below Average

Industry standards

$15M
$8.2M
Discord
$11M
NuvoAir
$15M
Canva
$30M
Kalshi

Benefits

Medical Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Flexible Work Hours

Paid Vacation

Paid Sick Leave

Annual Learning & Development stipend

Growth & Insights and Company News

Headcount

6 month growth

2%

1 year growth

4%

2 year growth

8%
SignalsAZ
Oct 24th, 2024
NuvoAir Medical to Open Pulmonary Clinic in Prescott

NuvoAir Medical to open pulmonary clinic in Prescott.

Business Wire
Apr 30th, 2024
Nuvoair Medical Partners With Privia Medical Group — Georgia To Help Transform Cardiopulmonary Care With Virtual-First Care Model

BOSTON--(BUSINESS WIRE)--NuvoAir Medical, a leading virtual health value-based specialty care platform with a multidisciplinary team of clinicians for patients with heart and lung conditions, is proud to announce their partnership with Privia Medical Group — Georgia (PMG). This collaboration marks a significant step forward in enhancing access to high-quality cardiopulmonary care for patients throughout the state of Georgia. Privia operates the state’s highest performing Accountable Care Organization (ACO), with more than 380 providers caring for over 515,000 patients. As the demand for specialty value-based care grows, especially in rural and underserved areas, NuvoAir Medical’s multidisciplinary team and physicians will extend specialty care for current PMG practice locations and their care teams. NuvoAir’s platform, innovative technology, and expertise will deliver personalized, proactive, on-demand cardiopulmonary care directly to patients’ homes. "By partnering with PMG — Georgia, we are excited to make an impact on lives of patients in Georgia with complex heart and lung conditions," said Lorenzo Consoli, CEO of NuvoAir Medical

Business Wire
Jan 30th, 2024
Nuvoair’S Air Next Spirometer Is Fda-Approved For In-Home Use

BOSTON--(BUSINESS WIRE)--Today, NuvoAir Medical announced its innovative Air Next Spirometer has received formal 510(k) clearance for in-home use as a full spirometer. 510(k) approval empowers NuvoAir to scale and expand clinical operations to ensure no patient with heart or lung conditions is left behind. 510(k) clearance allows Air Next to conduct full spirometry at home, providing extremely valuable clinical data that ensures patients can be monitored continuously. High-quality lung data empowers the NuvoAir clinical team to intervene when changes are detected and provide instantaneous care before lung function deteriorates to the point where hospitalizations are necessary. For patients with conditions like COPD, Asthma, or ALS, using this easy-to-use device at home means they don’t have to wait for an in-person appointment or plan the logistics for travel. “Air Next is capable of providing our care team with high-quality lung measurements from the comfort of our patients’ homes,” says Eric Harker, MD MPH MBA, and Chief Medical Officer at NuvoAir

HME News
Sep 12th, 2023
NuvoAir, health plan partner on virtual care model for COPD

BOSTON - NuvoAir, a value-based, integrated specialty care provider, and Security Health Plan of Wisconsin, a health plan and affiliate of Marshfield Clinic Health System, have launched a clinical research study to measure the impact of the company's virtual care model on reducing exacerbations, ER visits, hospitalizations, readmissions and overall costs for COPD patients.

Startup Italia
Aug 16th, 2023
Le 25 Startup Da Tenere D’Occhio Sotto L’Ombrellone. Dall’Ai Al Beauty Ecco I Settori Più Interessanti Per Gli Investitori

Se siete appassionati di innovazione e vi piace curiosare sull’ecosistema startup anche in vacanza (siete in buona compagnia, sappiatelo), eccovi servito un elenco di 25 startup da tenere d’occhio per questo secondo semestre 2023. La lista che vi proponiamo su StartupItalia è stata ripresa da HubSpot e ci è parsa così ben fatta che abbiamo deciso di riprenderla, aggiungendo alcuni elementi anche alla luce delle notizie che vi abbiamo raccontato in un anno così intenso dal punto di vista delle notizie tech. Dunque, partiamo.AISight.aiLa Bill and Melinda Gates Foundation è tra gli investitori di AISight.ai, startup di Berlino specializzata nel campo dell’intelligenza artificiale. Il suo servizio B2B è una dashboard di controllo sulla quale le aziende possono raccogliere un notevole numero di informazioni, ad esempio sulla propria clientela. Si tratta di uno strumento diffuso soprattutto in ambito retail, utile a negozi e attività.SoundHoundFinora SoundHound ha raccolto oltre 350 milioni di dollari. La startup californiana è attiva in uno dei campi di cui più si è parlato negli ultimi mesi

Recently Posted Jobs

Sign up to get curated job recommendations

NuvoAir is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →